NautaDutilh Brussels assists Shire, a UK/Irish biopharmaceutical company listed on the London Stock Exchange and on NASDAQ with its voluntary takeover bid on all outstanding shares of Movetis, a Belgian biotech company listed on Euronext Brussels since November last year following a 100mio IPO.
The all cash offer has a total consideration of 428mio EUR. The offer is recommended by the Movetis Board and reference shareholders have irrevocably committed to tender their shares.
The NautaDutilh team is led by Brussels partner Marc van der Haegen, assisted by Elke Janssens and Nicolas de Crombrugghe on the transaction side. Numerous other lawyers from NautaDutilh are involved for the tax, corporate, employment, life sciences and intellectual property aspects of the transaction.
